Cabot Stock Forecast, Price & News

-0.58 (-1.05 %)
(As of 08/2/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume290,317 shs
Average Volume379,110 shs
Market Capitalization$3.09 billion
P/E RatioN/A
Dividend Yield2.54%
30 days | 90 days | 365 days | Advanced Chart
Receive CBT News and Ratings via Email

Sign-up to receive the latest news and ratings for Cabot and its competitors with MarketBeat's FREE daily newsletter.

Cabot logo

About Cabot

Cabot Corp. is a global specialty chemicals and performance materials company. Its products are rubber and specialty grade carbon blacks, specialty compounds, fumed metal oxides, activated carbons, inkjet colorants, and aerogel. The company operates through the following segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The Reinforcement Materials segment involves the rubber blacks and elastomer composites product lines. The Performance Chemicals segment combines the specialty carbons and compounds and inkjet colorants product lines into the specialty carbons and formulations business. The Purification Solutions segment refers to the activated carbon business and the specialty fluids segment. Cabot was founded by Godfrey Lowell Cabot in 1882 and is headquartered in Boston, MA.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

2.61 out of 5 stars

Basic Materials Sector

37th out of 919 stocks

Miscellaneous Chemical Products Industry

1st out of 17 stocks

Analyst Opinion: 3.3Community Rank: 4.1Dividend Strength: 2.5Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Cabot (NYSE:CBT) Frequently Asked Questions

Is Cabot a buy right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cabot in the last twelve months. There are currently 1 sell rating, 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Cabot stock.
View analyst ratings for Cabot
or view top-rated stocks.

What stocks does MarketBeat like better than Cabot?

Wall Street analysts have given Cabot a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cabot wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Cabot?

Cabot saw a decrease in short interest during the month of July. As of July 15th, there was short interest totaling 1,270,000 shares, a decrease of 34.5% from the June 30th total of 1,940,000 shares. Based on an average daily trading volume, of 486,000 shares, the days-to-cover ratio is presently 2.6 days. Currently, 2.3% of the company's shares are short sold.
View Cabot's Short Interest

When is Cabot's next earnings date?

Cabot is scheduled to release its next quarterly earnings announcement on Monday, August 9th 2021.
View our earnings forecast for Cabot

How can I listen to Cabot's earnings call?

Cabot will be holding an earnings conference call on Tuesday, August 10th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Cabot's earnings last quarter?

Cabot Co. (NYSE:CBT) posted its earnings results on Sunday, May, 2nd. The specialty chemicals company reported $1.38 earnings per share for the quarter, topping analysts' consensus estimates of $0.97 by $0.41. The specialty chemicals company had revenue of $842 million for the quarter, compared to analyst estimates of $771.05 million. Cabot had a negative net margin of 5.17% and a positive trailing twelve-month return on equity of 19.21%. The company's revenue was up 18.6% compared to the same quarter last year. During the same period in the prior year, the business earned $0.77 earnings per share.
View Cabot's earnings history

How has Cabot's stock price been impacted by COVID-19?

Cabot's stock was trading at $29.91 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CBT shares have increased by 82.1% and is now trading at $54.48.
View which stocks have been most impacted by COVID-19

How often does Cabot pay dividends? What is the dividend yield for Cabot?

Cabot declared a quarterly dividend on Friday, July 9th. Investors of record on Friday, August 27th will be given a dividend of $0.35 per share on Friday, September 10th. This represents a $1.40 dividend on an annualized basis and a dividend yield of 2.57%. The ex-dividend date of this dividend is Thursday, August 26th.
View Cabot's dividend history

Is Cabot a good dividend stock?

Cabot pays an annual dividend of $1.40 per share and currently has a dividend yield of 2.54%. Cabot does not yet have a strong track record of dividend growth. The dividend payout ratio of Cabot is 67.31%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Cabot will have a dividend payout ratio of 26.97% next year. This indicates that Cabot will be able to sustain or increase its dividend.
View Cabot's dividend history.

What guidance has Cabot issued on next quarter's earnings?

Cabot updated its FY 2021 earnings guidance on Monday, May, 17th. The company provided EPS guidance of 4.700-4.950 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.070. The company issued revenue guidance of -.

What price target have analysts set for CBT?

7 brokers have issued 1 year target prices for Cabot's stock. Their forecasts range from $45.00 to $143.00. On average, they anticipate Cabot's stock price to reach $74.29 in the next twelve months. This suggests a possible upside of 36.4% from the stock's current price.
View analysts' price targets for Cabot
or view top-rated stocks among Wall Street analysts.

Who are Cabot's key executives?

Cabot's management team includes the following people:
  • Sean D. Keohane, President, Chief Executive Officer & Director
  • Erica McLaughlin, Chief Financial Officer & Senior Vice President
  • Patricia Hubbard, Chief Technology Officer & Senior Vice President
  • Hobart C. Kalkstein, SVP & President-Reinforcement Materials segment
  • Karen A. Kalita, Senior Vice President & General Counsel

What is Sean Keohane's approval rating as Cabot's CEO?

40 employees have rated Cabot CEO Sean Keohane on Glassdoor.com. Sean Keohane has an approval rating of 96% among Cabot's employees. This puts Sean Keohane in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Cabot's key competitors?

What other stocks do shareholders of Cabot own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cabot investors own include Pfizer (PFE), Broadcom (AVGO), Energy Transfer (ET), AT&T (T), Gilead Sciences (GILD), Intel (INTC), NVIDIA (NVDA), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and The Coca-Cola (KO).

What is Cabot's stock symbol?

Cabot trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBT."

Who are Cabot's major shareholders?

Cabot's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include New York State Common Retirement Fund (0.83%), Alliancebernstein L.P. (0.23%), Cambiar Investors LLC (0.09%), Sensible Financial Planning & Management LLC. (0.04%), Ziegler Capital Management LLC (0.04%) and Oregon Public Employees Retirement Fund (0.03%). Company insiders that own Cabot stock include Hobart Kalkstein and Karen A Kalita.
View institutional ownership trends for Cabot

Which major investors are selling Cabot stock?

CBT stock was sold by a variety of institutional investors in the last quarter, including Cambiar Investors LLC, State of Alaska Department of Revenue, State of Michigan Retirement System, New York State Common Retirement Fund, Arizona State Retirement System, and Sensible Financial Planning & Management LLC..
View insider buying and selling activity for Cabot
or view top insider-selling stocks.

Which major investors are buying Cabot stock?

CBT stock was purchased by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., Hillsdale Investment Management Inc., Advisors Asset Management Inc., Cornerstone Investment Partners LLC, New Mexico Educational Retirement Board, Boston Trust Walden Corp, Zurcher Kantonalbank Zurich Cantonalbank , and Carolina Wealth Advisors LLC.
View insider buying and selling activity for Cabot
or or view top insider-buying stocks.

How do I buy shares of Cabot?

Shares of CBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cabot's stock price today?

One share of CBT stock can currently be purchased for approximately $54.48.

How much money does Cabot make?

Cabot has a market capitalization of $3.09 billion and generates $2.61 billion in revenue each year. The specialty chemicals company earns $-238,000,000.00 in net income (profit) each year or $2.08 on an earnings per share basis.

How many employees does Cabot have?

Cabot employs 4,500 workers across the globe.

What is Cabot's official website?

The official website for Cabot is www.cabot-corp.com.

Where are Cabot's headquarters?

Cabot is headquartered at TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210.

How can I contact Cabot?

Cabot's mailing address is TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210. The specialty chemicals company can be reached via phone at (617) 345-0100 or via email at [email protected]

This page was last updated on 8/2/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.